Interferon-b and mycophenolic acid are potent inhibitors of Middle East respiratory syndrome coronavirus in cell-based assays

Received 4 December 2013 Accepted 5 December 2013 Integrated Research Facility, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederik, MD, USA Emerging Viral Pathogens Section, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Frederick, MD, USA Department of Microbiology and Immunology, University of Maryland School of Medicine, Baltimore, MD, USA

[1]  Gail,et al.  International Severe Acute Respiratory and emerging Infections Consortium Partners^ , 2016 .

[2]  U. Emirates.  b Middle East respiratory syndrome coronavirus (MERS-CoV): update , 2014 .

[3]  K. To,et al.  Broad-spectrum antivirals for the emerging Middle East respiratory syndrome coronavirus , 2013, Journal of Infection.

[4]  T. Bestebroer,et al.  MERS-coronavirus replication induces severe in vitro cytopathology and is strongly inhibited by cyclosporin A or interferon-α treatment , 2013, The Journal of general virology.

[5]  Christian Drosten,et al.  Commentary: Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group , 2013, Journal of Virology.

[6]  Y. Guan,et al.  Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures , 2013, Journal of Virology.

[7]  R. Geffers,et al.  Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential , 2013, mBio.

[8]  A. Osterhaus,et al.  Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia. , 2012, The New England journal of medicine.

[9]  J. Kwekkeboom,et al.  Mycophenolic acid augments interferon‐stimulated gene expression and inhibits hepatitis C Virus infection in vitro and in vivo , 2012, Hepatology.

[10]  Michael G. Katze,et al.  Into the Eye of the Cytokine Storm , 2012, Microbiology and Molecular Reviews.

[11]  Stephan Ludwig,et al.  Disruption of virus-host cell interactions and cell signaling pathways as an anti-viral approach against influenza virus infections , 2011, Biological chemistry.

[12]  M. Parida,et al.  Cellular IMPDH enzyme activity is a potential target for the inhibition of Chikungunya virus replication and virus induced apoptosis in cultured mammalian cells. , 2011, Antiviral research.

[13]  B. Loriod,et al.  Gene Expression Signature-Based Screening Identifies New Broadly Effective Influenza A Antivirals , 2010, PloS one.

[14]  B. Haagmans,et al.  Mycophenolic acid inhibits hepatitis C virus replication and acts in synergy with cyclosporin A and interferon-alpha. , 2006, Gastroenterology.

[15]  Jongdae Lee,et al.  Enhancement of the infectivity of SARS-CoV in BALB/c mice by IMP dehydrogenase inhibitors, including ribavirin , 2006, Antiviral Research.

[16]  E. De Clercq,et al.  The Predominant Mechanism by Which Ribavirin Exerts Its Antiviral Activity In Vitro against Flaviviruses and Paramyxoviruses Is Mediated by Inhibition of IMP Dehydrogenase , 2005, Journal of Virology.

[17]  D. Smee,et al.  Identification of active antiviral compounds against a New York isolate of West Nile virus. , 2002, Antiviral research.

[18]  D. Smee,et al.  Antiviral Activity and Mode of Action Studies of Ribavirin and Mycophenolic Acid against Orthopoxviruses in Vitro , 2001, Antiviral chemistry & chemotherapy.

[19]  H. Frost,et al.  The American Journal of Hygiene , 1920, Science.